GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (LTS:0KCS) » Definitions » Institutional Ownership

OPKO Health (LTS:0KCS) Institutional Ownership : 15.96% (As of May. 11, 2024)


View and export this data going back to 2018. Start your Free Trial

What is OPKO Health Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OPKO Health's institutional ownership is 15.96%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OPKO Health's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OPKO Health's Float Percentage Of Total Shares Outstanding is 53.16%.


OPKO Health Institutional Ownership Historical Data

The historical data trend for OPKO Health's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Institutional Ownership Chart

OPKO Health Historical Data

The historical data trend for OPKO Health can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 17.96 18.21 18.57 17.02 16.62 17.08 19.06 18.26 16.08 15.96

OPKO Health Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


OPKO Health (LTS:0KCS) Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

OPKO Health (LTS:0KCS) Headlines

No Headlines